Prime Medicine, Inc.(NASDAQ:PRME) 
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime...
Website: https://www.primemedicine.com
Founded: 2019
IPO Price: $17 (Oct 20, 2022)
Full Time Employees: 150
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.53
H 1.54
L 1.37
C 1.41
V 2,742,943
10EMA 1.41
20EMA 1.41
60EMA 1.41
120EMA 1.41
250EMA 1.41